0 results available. Select is focused ,type to refine list, press Down to open the menu,
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...
The following section summarizes insights on GSK plc DRC's Unadjusted EBIT CAGR (10y):
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Unadjusted EBIT CAGR (10y) in the growth category include:
Ten-year compound annual growth rate in unadjusted EBIT.
The chart above depicts the distribution of unadjusted ebit cagr (10y) for companies operating in the Healthcare sector in the Developed economic region. Over 250 companies were considered in this analysis, and 242 had meaningful values. The average unadjusted ebit cagr (10y) of companies in the sector is 5.9% with a standard deviation of 8.5%.
GSK plc DRC's Unadjusted EBIT CAGR (10y) of 1.1% ranks in the 22.1% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 252 |
| Included Constituents | 242 |
| Min | -21.7% |
| Max | 26.2% |
| Median | 6.0% |
| Mean | 5.9% |
| Standard Deviation | 8.5% |
You can find companies with similar unadjusted ebit cagr (10y) using this stock screener.